Management
The Regulator of Tomorrow
The challenge isn’t just how to regulate new technologies. Technology is changing the capabilities of regulators themselves in ways not previously imagined.
Management
Biden Seeks to Halt or Delay Trump’s ‘Midnight Regulations’
The new president took several immediate actions to start undoing Trump’s deregulatory agenda.
Management
GovExec Daily: Federal Land Management During Trump's Term
Bloomberg Government's Kellie Lunney joins the show to discuss the outgoing president's public lands legacy.
Management
GovExec Daily: How Biden Can Make Government Work Better
Peter H. Schuck joins the podcast to discuss how the president-elect can realign government to meet more people's needs.
Oversight
GovExec Daily: Getting the Best People into the Civil Service
Dr. Lisa Parshall and Dr. Jim Twombly join the podcast again to talk about how to make public service jobs more attractive to more people, including paying feds more.
Oversight
GovExec Daily: The Administrative State Under the Trump Presidency
Dr. Lisa Parshall and Dr. Jim Twombly join the podcast to discuss their book on the outgoing president's effects on the federal government.
Oversight
Environmental Groups Allege Texas Rubber-Stamped Industrial Plants' Pollution — and that the EPA Looked the Other Way
The groups are suing the EPA, saying it failed to address concerns that air permits issued to big industrial facilities didn’t meet federal standards.
Management
Democratic Lawmakers Seek to Increase Oversight of ‘Midnight’ Regulations
Bill would require the Government Accountability Office to submit various reports to Congress.
Oversight
GovExec Daily: Midnight Regulations During the Transition
Courtney Bublé joins the podcast to discuss the outgoing administration's last-minute rulemaking.
Management
New HHS Policy Requires All Information to Be Released for Upcoming Rules
Experts criticize and question its purpose as the Trump administration winds down.
Management
GovExec Daily: How Biden Can Rebuild Government
Philip K. Howard joins the podcast to discuss how the incoming administration can reconfigure bureaucracy for better government.
Oversight
Trump Races to Weaken Environmental and Worker Protections, and Implement Other Last-Minute Policies, Before Jan. 20
The Trump administration is rushing to approve dozens of eleventh-hour policy changes. Among them: The Justice Department is fast-tracking a rule that could reintroduce firing squads and electrocutions to federal executions.
Management
HHS Seeks Feedback on Pandemic Regulatory Actions
The Trump administration is making a final push for deregulation during lame duck period.
Management
Regulatory Affairs Veteran Shares Insights on Trump’s Cutbacks and What Lies Ahead for Biden
"Judge the person relative to what you want them to do," said Jim Tozzi, on selecting a new Office of Information and Regulatory Affairs administrator.
Management
What Will Regulatory Policy Look Like Under President Biden?
Experts predict the incoming Biden administration will work immediately to undo four years of deregulation under Trump.
Management
Global Media Agency CEO Revokes Regulation Clarifying ‘Firewall’ Protecting Journalistic Integrity
The move is at most symbolic and a "weird Hail Mary" days ahead of the presidential election, said a whistleblower attorney.
Workforce
GovExec Daily: Taming the Bureaucracy
Author Mark Schwartz joins the podcast to discuss how to make government work better for everyone.
Oversight
GovExec Daily: The Latest Deregulation Memo
Courtney Bublé joins the podcast to discuss the August OMB memo on agencies soften rules for pursuing regulatory violators.
Management
White House Presses Agencies to Soften Rules for Pursuing Regulatory Violators
“The government should bear the burden of proving an alleged violation of law; the subject of enforcement should not bear the burden of proving compliance,” memo says.
Oversight
FDA Is Departing from Long-Standing Procedures to Deal with Public Health Crises, and This May Foreshadow Problems for COVID-19 Vaccines
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Almost There!
Help us tailor content specifically for you: